Tags » GlaxoSmithKline

GSK’s New CEO Emma Walmsley Has a Strong Start Out of the Gate

I had the pleasure of spending part of the afternoon yesterday with GlaxoSmithKline’s new CEO, Emma Walmsley, who stopped by for a visit with Fortune… 1,204 more words


Chemotherapy Market – Global Industry Size, Share, Analysis, Trend & Forecast to 2025

Global Chemotherapy Market offers comprehensive insights into the industry trends, growth drivers, significant challenges, lucrative opportunities, latest technological advancements, and the competitive landscape. The market report also scrutinizes the different prospects in the market for numerous investors and stakeholders by distinguishing the trending factors responsible for the high growth of the market as well as the major initiatives undertaken by them. 384 more words

Pharmaceuticals And Healthcare

GlaxoSmithKline cutting manufacturing jobs at Barnard Castle site in U.K.

GlaxoSmithKline will cut jobs at its Barnard Castle manufacturing site in the U.K., despite having plowed money into expanding it in the past two years. 72 more words


75 Firms going Ex-Dividend next week, including Starbucks, IBM and Pfizer

There are several well known large cap stocks going ex-dividend next week including the following ten Top 100 Dividend Stocks: IBM, Starbucks, BB&T, Emerson Electric, GlaxoSmithKline, Invesco, Pfizer, Wal-Mart, Capital One and Exxon Mobil… 262 more words

Ex-Dividend Dates


Il colosso farmaceutico britannico e numero uno dei vaccini a livello mondiale, GlaxoSmithKline, trucca le carte. Alcuni ricercatori indiani, infatti, hanno scoperto che un recente rapporto inviato all’EMA, l’Agenzia europea per il farmaco, contiene dati incompleti e fuorvianti: quindi tali da non fornire un attendibile profilo circa la sicurezza di un vaccino, Infanrix Hexa. 974 more words


Naratriptan (trade names include Amerge and Naramig) is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5mg tablets. 49 more words


Aiken County manufacturing plant sold to Connecticut pharmaceutical Avara

By Michael Smith

An Aiken County pharmaceutical manufacturer officially has a new owner, providing a dose of hope amid supply and regulatory struggles.

Connecticut-based Avara Pharmaceutical Services Inc. 461 more words